A bispecific antibody against human IgE and human FcγRII that inhibits antigen-induced histamine release by human mast cells and basophils

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 59, Issue 7, 2004, Pages 772-780

  Tam, S W ^a,c   Demissie, S ^a   Thomas, D ^a   Daeron M ^b  

^a Tanox Biosystems Inc   (United States)

^b CENTRE DE RECHERCHE DES CORDELIERS   (France)

^c CHARLES RIVER LABORATORIES   (United States)

Author keywords

Basophils; Fc RIIB; Fc RI; Mast cells; Negative regulation; Therapeutic antibody

Indexed keywords

ANTIGEN; BISPECIFIC ANTIBODY; FC RECEPTOR; FC RECEPTOR II; HISTAMINE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BASOPHIL; BIOENGINEERING; BLOOD CELL; CROSS LINKING; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; MAST CELL; MOLECULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; SENSITIZATION; UMBILICAL CORD BLOOD;

ANTIBODIES, BISPECIFIC; ANTIGENS; BASOPHILS; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE; HISTAMINE ANTAGONISTS; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; RECEPTOR AGGREGATION; RECEPTORS, IGE; RECEPTORS, IGG;

EID: 3042778582     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2004.00332.x     Document Type: Article

References (44)

1. TURNER H, KINET JP. Signalling through the high-affinity IgE receptor FcεRI. Nature 1999;402:B24.
2. RETH MG. Antigen receptor tail clue. Nature 1989;338:383-384.
3. JOUVIN MH, ADAMCZEWSKI M, NUMEROF R, LETOURNEUR O, VALLÉ A, KINET JP. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J Biol Chem 1994;269:5918-5925.
4. CAMBIER JC. Antigen and Fc receptor signaling: the awsome power of the immunoreceptor tyrosine based activation motif (ITAM). J Immunol 1995;155:3281-3285.
5. TAMIR I, GAMBIER JC. Antigen receptor signaling: integration of protein tyrosine kinase functions. Oncogene 1998;17:1353-1364.
6. NADLER MJ, MATTHEWS SA, TURNER H, KINET J-P. Signal transduction by the high-affinity immunoglobulin E receptor Fc epsilon RI: coupling form to function. Adv Immunol 2000;76:325-355.
7. DAËRON M. Fc receptor biology. Annu Rev Immunol 1997;15:203-234.
8. DAËRON M, LATOUR S, MALBEC O. ESPINOSA E. PINA P. PASMANS S et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of FcγRIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995;3:635-646.
9. VIVIER E, DAËRON M. Immunoreceptor tyrosine-based inhibition motifs. Immunol Today 1997;18:286-291.
10. DAËRON M, MALBEC O, LATOUR S, AROCK M, FRIDMAN WH. Regulation of high-affinity IgE receptor-mediated mast cell activation by murine low-affinity IgG receptors. J Clin Invest 1995;95:577-585.
11. MALBEC O, FONG D, TURNER M, TYBULEWICZ VLJ, CAMBIER JC, FRIDMAN WH et al. FcεRI-associated lyn-dependent phosphorylation of FcγRIIB during negative regulation of mast cell activation. J Immunol 1998;160:1647-1658.
12. FONG DC, MALBEC O, AROCK M, CAMBIER JC, FRIDMAN WH, DAËRON M. Selective in vivo recruitment of the phosphatidylinositol phosphatase SHIP by phosphorylated FcγRIIB during negative regulation of IgE-dependent mouse mast cell activation. Immunol Letters 1996;54:83-91.
13. ONO M, BOLLAND S, TEMPST P, RAVETCH JV. Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FcγRIIB. Nature 1996;383:263-266.
14. BRUHNS P, VÉLY F, MALBEC O, FRIDMAN WH, VIVIER E, DAËRON M. Molecular basis of the recruitment of the SH2 domain-containing inositol 5-phosphatases SHIP1 and SHIP2 by FcγRIIB. J Biol Chem 2000;275:37 357-37 364.
15. LESOURNE R, BRUHNS P, FRIDMAN WH, DAËRON M. Insufficient phosphorylation prevents FcγRIIB from recruiting the SH2 domain-containing protein tyrosine phosphatase SHP-1. J Biol Chem 2001;276:6327-6336.
16. DAËRON M, VIVIER E. Biology of immunoreceptor tyrosine-based inhibition motif-bearing molecules. Cur Top Microbiol Immunol 1999;244:1-12.
17. LONG EO. Regulation of immune responses through inhibitory receptors. Annu Rev Immunol 1999;17:875-904.
18. CHOQUET D, PARTISETI M, AMIGORENA S, BONNEROT C, FRIDMAN WH, KORN H. Cross-linking of IgG receptors inhibits membrane immunoglobulin-stimulated calcium influx in B lymphocytes. J Cell Biol 1993;121:355-363.
19. SCHARENBERG AM, EL-HILLAL O, FRUMAN DA, BEITZ LO, LI Z, LIN S et al. Phosphatidylinositol-3,4,5-triphosphate (PtdIns-3,4,5-P3)/Tec kinase-dependent calcium signaling pathway: a target for SHIP-mediated inhibitory signals. EMBO J 1998;17:1961-1972.
20. TAMIR I, STOLPA JC, HELGASON CD, NAKAMURA K, BRUHNS P, DAËRON M et al. The RasGAP-binding protein p62dok is a mediator of inhibitory FcγRIIB signals in B cells. Immunity 2000;12:347-358.
21. UJIKE A, ISHIKAWA Y, ONO M, YUASA T, YOSHINO T, FUKUMOTO M et al. Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med 1999;189:1573-1579.
22. QIU WQ, de BRUIN D, BROWNSTEIN BH, PEARSE R, RAVETCH JV. Organization of the human and mouse low-affinity FcγR genes: duplication and recombination. Science 1990;248:732-735.
23. SAITO H, EBISAWA M, TACHIMOTO H, SHICHIJO M, FUKAGAWA K, MATSUMOTO K et al. Selective growth of human mast cells induced by Steel factor, IL-6, and prostaglandin E2 from cord blood mononuclear cells. J Immunol 1996;157:343-350.
24. CHO SH, TAM SW, DEMISSIE-SANDERS S, FILLER SA, OH CK. Production of plasminogen activator inhibitor-1 by human mast cells and its possible role in asthma. J Immunol 2000;165:3154-3161.
25. VALENT P, SPANBLOCHL E, SPERR WR, ZSEBO KM, AGIS H, STROBL H et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/ kit-ligand in long-term culture. Blood 1992;80:2237-2245.
26. GREENMAN J, TUTT AL, GEORGE AJ, PULFORD KAF, STEVENSON GT, GLENNIE MJ. Characterization of a new monoclonal anti-FcγRII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors. Mol Immunol 1991;28:1243-1254.
27. SUN LK, LIOU RS, SUN NC, GOSSETT LA, SUN C, DAVIS FM et al. Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity. J Immunol 1991;146:199-205.
28. LAMOYI E, NISONOFF A. Preparation of F(ab')2 fragments from mouse IgG of various subclasses. J Immunol Methods 1983;56:235-243.
29. GLENNIE MJ, MCBRIDE HM, WORTH AT, STEVENSON GT. Preparation and performance of bispecific F(ab' gamma)2 antibody containing thioether-linked Fab' gamma fragments. J Immunol 1987;139:2367-2375.
30. VAN TOORENENBERGEN AW, AALBERSE RC. IgG4 and passive sensitization of basophil leukocytes. Int Arch Allergy Appl Immunol 1981;65:432-440.
31. ZHU D, KEPLEY C, ZHANG LM, ZHANG K, SAXON A. A novel human immunoglobulin Fcγ-Fcε bifunctional fusion protein inhibits FcεRI-mediated degranulation. Nature Medicine 2002;8:518-521.
32. KULCZYCKI A, METZGER H. The interaction of IgE with rat basophilic leukemia cells. II: quantitative aspects of the binding reaction. J Exp Med 1974;140:1676-1695.
33. STUART SG, SIMISTER NE, CLARKSON SB, KACINSKI BM, SHAPIRO M, MELLMAN I. Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J 1989;8:3657-3666.
34. MAURER D, FIEGIGER E, REININGER B, WOLFFWINISKI B, JOUVIN M-H, KILGUS O et al. Expression of a functional high affinity immunoglobulin E receptor (FcεRI) on monocytes of atopic individuals. J Exp Med 1994;179:745-750.
35. GOUNNI AS, LAMKHIOUED B, OCHIAL K, TANAKA Y, DELAPORTE E, CAPRON A et al. High-affinity IgE receptor on eosinophils is involved in defence against parasites. Nature 1994;367:183-186.
36. CAPRON M, MORITA M, WOERLY G, LENGRAND F, GOUNNI AS, DELAPORTE E et al. Differentiation of eosinophils from cord blood cell precursors: kinetics of Fc epsilon RI and Fc epsilon RII expression. Int Arch Allergy Immunol 1997;113:48-50.
37. ARM JP, NWANKWO C, AUSTEN KF. Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. J Immunol 1997;159:2342-2349.
38. KUBAGAWA H, BURROWS PD, COOPER MD. A novel pair of immunoglobulin-like receptors expressed by B cells and myeloid cells. Proc Natl Acad Sci USA 1997;94:5261-5266.
39. LIÉNARD H, BRUHNS P, MALBEC O, FRIDMAN WH, DAËRON M. Signal regulatory proteins negatively regulate immunoreceptor-dependent cell activation. J Biol Chem 1999;274:32 493-32 499.
40. KATZ HR, VIVIER E, CASTELLS MC, MCCORMICK MJ, CHAMBERS JM, AUSTEN KF. Mouse mast cell gp49B1 contains two immunoreceptor tyrosine-based inhibition motifs and suppresses mast cell activation upon coligation with FcεRI. Proc Natl Acad Sci USA 1996;93:10 809-10 814.
41. UEHARA T, BLÉRY M, KANG D-W, CHEN C-C, HO LH, GARTLAND GL et al. Inhibition of IgE-mediated mast cell activation by the paired Ig-like receptor PIR-B. J Clin Invest 2001;108:1041-1050.
42. LU-KUO JM, JOYAL DM, AUSTEN KF, KATZ HR. gp49B1 inhibits IgE-initiated mast cell activation through both immunoreceptor tyrosine-based inhibitory motifs, recruitment of src homology 2 domain-containing phosphatase-1, and suppression of early and late calcium mobilization. J Biol Chem 1999;274:5791-5796.
43. BLÉRY M, KUBAGAWA H, CHEN CC, VELY F, COOPER MD, VIVIER E. The paired Ig-like receptor PIR-B is an inhibitory receptor that recruits the protein-tyrosine phosphatase SHP-1. Proc Natl Acad Sci USA 1998;95:2446-2451.
44. GUPTA N. SCHARENBERG AM, BURSHTYN DN, WAGTMANN N, LIOUBIN MN, ROHRSCHNEIDER LR et al. Negative signaling pathways of the killer cell inhibitory receptor and Fc gamma RIIb1 require distinct phosphatases. J Exp Med 1997;186:473-478.